← All indications
Respiratory Aspiration
Inhaling liquid or solids, such as stomach contents, or other FOREIGN OBJECTS, into the RESPIRATORY TRACT. When this causes severe lung damage, it is called ASPIRATION PNEUMONIA.
Subtype terms (1)
More specific conditions that are subtypes of Respiratory Aspiration in the MeSH hierarchy.
- Respiratory Aspiration of Gastric Contents
3 drugs (1 approved, 2 experimental)
Drugs by status
Phase 4 trials (19)
Phase 2 trials (3)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (26)
- Jazz Pharmaceuticals
- Novartis
- Amphastar Pharmaceuticals
- GlaxoSmithKline
- NeuTec Pharma
- Boehringer Ingelheim
- University of Pennsylvania
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
- Erzincan University
- Hospital General Universitario Gregorio Marañon
- Postgraduate Institute of Medical Education and Research
- Sir Ganga Ram Hospital
- University of New Mexico
- University of Bern
- University of Zurich
- Aga Khan University
- Fujian Medical University
- Istanbul University
- University of British Columbia
- Jiao Tong University
- World Anti-Doping Agency
- Pulmonary Research Institute of Southeast Michigan
- Ben Gurion University
- Department of Veteran Affairs
- Government of Kyrgyzstan
- Government of Spain
Organization Involved with Phase 3 Indications (28)
- Theravance
- Gilead Sciences
- APT Pharmaceuticals, Inc.
- Sunovion
- University of Pittsburgh
- Baqiyatallah Medical Sciences University
- Case Western Reserve University
- Chulalongkorn University
- Mansoura University
- McGill University
- University of Ioannina
- University of Saskatchewan
- University of Tehran
- Tel Aviv University
- University of California, San Francisco
- University of Copenhagen
- Covance
- University of Amsterdam
- Amneal Pharmaceuticals
- Isfahan University
- Chiltern International
- Universitaetsklinikum Schleswig-Holstein
- Dutch Burns Foundation
- ClinPhone, Inc.
- Linde AG
- Air Liquide
- Respirent Pharmaceuticals Co Ltd.
- BECRO Ltd.
Organization Involved with Phase 2 Indications (41)
- Advanced Inhalation Therapies Ltd
- AstraZeneca
- Sanofi
- Alkermes
- Aradigm Corporation
- Merz
- Biosplice Therapeutics
- Pulmotect, Inc.
- Savara Inc.
- National Center for Research Resources (NCRR)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Changhai Hospital
- University of London
- Harvard University
- Monash University
- Oregon Health and Science University
- Queen's University, Belfast
- RWTH Aachen University
- Tufts University
- University of Dundee
- University of Edinburgh
- Justus Liebig University Giessen
- University of Miami
- University of Milan
- Columbia University
- University of Cincinnati
- Papworth Hospital NHS Foundation Trust
- Moscow State University
- Government of Russia
- +11 more
Organization Involved with Phase 1 Indications (26)
- Acorda Therapeutics
- Pearl Therapeutics
- Vectura
- Pfizer
- Shionogi
- Union Therapeutics
- Bayer
- Cellular Biomedicine Group Ltd.
- OptiNose AS
- Pieris Pharmaceuticals GmbH
- Reig Jofre Group
- Cystic Fibrosis Foundation Therapeutics
- National Institute of Environmental Health Sciences (NIEHS)
- Cedars-Sinai Medical Center
- Niigata University Medical & Dental Hospital
- Oxford Brookes University
- University of Groningen
- University of Thessaly
- Wake Forest University
- Celerion
- Nucleus Network Ltd
- WCCT Global
- University of North Carolina at Chapel Hill
- DanTrials ApS, Copenhagen, Denmark
- Inova Health System
- IQVIA
Organization Involved with Other Experimental Indications (33)
- ResMed
- National Institute on Drug Abuse (NIDA)
- Aarhus University
- Duke University
- New York University
- NHS Lothian
- Seoul National University
- Tulane University
- University of Oslo
- University of Oulu
- University of Southern California
- University of Tennessee
- University of Toronto
- University of Bordeaux
- Yonsei University
- Taichung Veterans General Hospital
- Icahn School of Medicine at Mount Sinai
- University of Vienna
- Umea University
- University of Indonesia
- National Taiwan University
- Yeungnam University
- Winthrop University
- Fraunhofer
- Medtronic
- Society of Family Planning
- Bezmialem University
- Aix-University of Marseille
- Orion Corporation
- ResMed Foundation
- +3 more